Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Segment 3DPrint

K-Number: K211966 · 2022-05-06

ApplicantMedviso AB
Decision Date2022-05-06
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Segment 3DPrint is a medical device manufactured by Medviso AB. It received FDA 510(k) clearance on 2022-05-06 under approval number K211966. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Segment 3DPrint?

Segment 3DPrint is a medical device that received FDA 510(k) clearance on 2022-05-06. It is manufactured by Medviso AB. The 510(k) number is K211966.

When was Segment 3DPrint approved by the FDA?

Segment 3DPrint received FDA 510(k) clearance on 2022-05-06, under approval number K211966.

What company makes Segment 3DPrint?

Segment 3DPrint is manufactured by Medviso AB.

What is the FDA product code for Segment 3DPrint?

The FDA product code for Segment 3DPrint is LLZ.

Other Devices by Medviso AB

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.